HEPATOCYTE GROWTH FACTOR RECEPTOR

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 11:31:57 GMT 2023` Edited by `admin` on `Sat Dec 16 11:31:57 GMT 2023`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	QA085PMU8Q
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

HEPATOCYTE GROWTH FACTOR RECEPTOR

Common Name

English

MET RECEPTOR TYROSINE KINASE

Common Name

English

TYROSINE-PROTEIN KINASE MET

Common Name

English

C-MET

Common Name

English

SF RECEPTOR

Common Name

English

HGF/SF RECEPTOR

Common Name

English

HGFR

Common Name

English

AUTS9

Common Name

English

PROTO-ONCOGENE C-MET

Common Name

English

SCATTER FACTOR RECEPTOR

Common Name

English

Code System Code Type Description

UNIPROT

P08581

Created by admin on Sat Dec 16 11:31:59 GMT 2023 , Edited by admin on Sat Dec 16 11:31:59 GMT 2023

PRIMARY

FDA UNII

QA085PMU8Q

Created by admin on Sat Dec 16 11:31:59 GMT 2023 , Edited by admin on Sat Dec 16 11:31:59 GMT 2023

PRIMARY

Related Record Type Details


					G86X5QQ7M5

BAFISONTAMAB

INHIBITOR -> TARGET


					CYJ9ATV1IJ

PF-04217903

INHIBITOR -> TARGET

Qualification:

Amount:


					R15ZW356HN

TELISOTUZUMAB

INHIBITOR -> TARGET


					TY34L4F9OZ

CAPMATINIB

INHIBITOR -> TARGET

Amount:


					976X9VXC3Z

TELISOTUZUMAB VEDOTIN

INHIBITOR -> TARGET

Interaction Type:

BINDING

Amount:


					15UDG410PN

JNJ-38877605

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					0JSR7Z0NB6

AMIVANTAMAB

INHIBITOR -> TARGET


					4SP7R879Y5

Dalmelitinib

INHIBITOR -> TARGET

Amount:


					H2OL3Q4XRD

PAMUFETINIB

INHIBITOR -> TARGET

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					7JTT036WGX

Gumarontinib

INHIBITOR -> TARGET

Amount:


					A3MMS6HDO1

BMS-777607

INHIBITOR -> TARGET


					PMR8E5X493

Zgwatinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					KC2JC2ZA04

Zanzalintinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					PJ4H73IL17

TIVANTINIB

INHIBITOR -> TARGET

Amount:


					N2H0RP6IHR

Davutamig

INHIBITOR -> TARGET

Interaction Type:

BINDING

Qualification:

Amount:


					5NZ2A38SW2

Zgwatinib monodeuterated

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					7Q29OXD98N

GLESATINIB

INHIBITOR -> TARGET


					9WYX65A5C2

DIHEXA

ACTIVATOR -> TARGET

Amount:


					4T3Z98RR86

Unecritinib

INHIBITOR -> TARGET

Amount:


					08WG8S0L8D

AMG-337

INHIBITOR -> TARGET

Comments:

Little efficacy shown in Phase II trials.

Qualification:

IC50

Amount:


					2WZP8A9VFN

VEBRELTINIB

INHIBITOR -> TARGET


					PW3Q92Z6A4

NINGETINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					X3U67W8G5W

Pamvatamig

INHIBITOR -> TARGET

Interaction Type:

IN-VIVO

Amount:


					53AH36668S

CRIZOTINIB

INHIBITOR -> TARGET

Comments:

In vitro studies in human liver microsomes demonstrated that crizotinib is a time-dependent inhibitor of CYP3A.

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					1IJV77EI07

TEPOTINIB

INHIBITOR -> TARGET


					51WEW898IJ

RILOTUMUMAB

INHIBITOR -> TARGET

Comments:

Blocks HGF binding to receptor.

Amount:


					XT5T3BT4QP

Vabametkib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					UN4C7N5KVB

PF-04254644

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					MS1J9720WC

ONARTUZUMAB

INHIBITOR -> TARGET


					9FJ3MBL7XW

TSN-084

INHIBITOR -> TARGET

Interaction Type:

PRECLINICAL

Amount:


					EFL78M2T2C

GEMNELATINIB

INHIBITOR -> TARGET

Amount:


					5OGS5K699E

MERESTINIB

INHIBITOR -> TARGET

Amount:


					WH8SQN09KJ

SGX-523

INHIBITOR -> TARGET


					SO9S6QZB4R

AMUVATINIB

INHIBITOR -> TARGET

Amount:


					TTY12Q00LY

Elzovantinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					GG91UXK2M5

TEREVALEFIM

AGONIST -> TARGET

Amount:


					T678746713

ALTIRATINIB

INHIBITOR -> TARGET


					1969ZJE05Q

CEP-40783

INHIBITOR -> TARGET


					MO4K3GDN1I

EMIBETUZUMAB

INHIBITOR -> TARGET


					IT54DZ1478

EMI-137

LIGAND->TARGET

Amount:


					2A2DA6857R

SAVOLITINIB

INHIBITOR -> TARGET

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:NUMBER(CALCULATED)	CHEMICAL